September 15, 2025
RNA-LNP Therapeutics Startup Axelyf Seeded to Conquer Delivery Challenges
Former Moderna executive Örn Almarsson, PhD, hopes to expand RNA therapeutic targets for autoimmune disease using proprietary lipid chemistry and AI
Oskar Fannar Vilmundarson
September 15, 2025
hopp receives the Iceland fastest growing start-up award!
Exceptional growth for start-up company hopp
Óskar Fannar Vilmundarson
September 15, 2025
To infinity and beyond!
The history of Icelandic VC funds and the Icelandic start-up ecosystem.
Óskar Fannar Vilmdunarson
September 15, 2025
DTE Concludes a Total Investment Round of $16M in 2023
DTE has successfully managed to close a $16M Series A round in 2023
Óskar Fannar Vilmundarson
September 15, 2025
Oculis rings the Nasdaq Iceland opening bell
Oculis became dual-listed on the Nasdaq Iceland Main Market, complementing its existing listing on the Nasdaq Global Market in the U.S. (Nasdaq: OCS).
Óskar Fannar Vilmundarson
September 15, 2025
Avilabs lands €8M for airline disruption management technology
AviLabs has secured €8M in Series A funding to tackle airline passenger disruptions.
Óskar Fannar Vilmundarson
